183 related articles for article (PubMed ID: 20883178)
1. Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB.
Parajó Y; D'Angelo I; Welle A; Garcia-Fuentes M; Alonso MJ
Drug Deliv; 2010 Nov; 17(8):596-604. PubMed ID: 20883178
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles based on PLGA:poloxamer blends for the delivery of proangiogenic growth factors.
d'Angelo I; Garcia-Fuentes M; Parajó Y; Welle A; Vántus T; Horváth A; Bökönyi G; Kéri G; Alonso MJ
Mol Pharm; 2010 Oct; 7(5):1724-33. PubMed ID: 20681555
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction.
Hao X; Silva EA; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Wärdell E; Brodin LA; Mooney DJ; Sylvén C
Cardiovasc Res; 2007 Jul; 75(1):178-85. PubMed ID: 17481597
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
5. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier.
Lee YM; Park YJ; Lee SJ; Ku Y; Han SB; Klokkevold PR; Chung CP
J Periodontol; 2000 Mar; 71(3):418-24. PubMed ID: 10776929
[TBL] [Abstract][Full Text] [Related]
6. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
[TBL] [Abstract][Full Text] [Related]
7. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration.
De la Riva B; Sánchez E; Hernández A; Reyes R; Tamimi F; López-Cabarcos E; Delgado A; Evora C
J Control Release; 2010 Apr; 143(1):45-52. PubMed ID: 19963026
[TBL] [Abstract][Full Text] [Related]
8. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.
Tan Q; Tang H; Hu J; Hu Y; Zhou X; Tao Y; Wu Z
Int J Nanomedicine; 2011; 6():929-42. PubMed ID: 21720505
[TBL] [Abstract][Full Text] [Related]
10. Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB.
Davies NH; Schmidt C; Bezuidenhout D; Zilla P
Tissue Eng Part A; 2012 Jan; 18(1-2):26-34. PubMed ID: 21895488
[TBL] [Abstract][Full Text] [Related]
11. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.
Jean M; Smaoui F; Lavertu M; Méthot S; Bouhdoud L; Buschmann MD; Merzouki A
Gene Ther; 2009 Sep; 16(9):1097-110. PubMed ID: 19440230
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-hyaluronic acid/VEGF loaded fibrin nanoparticles composite sponges for enhancing angiogenesis in wounds.
Mohandas A; Anisha BS; Chennazhi KP; Jayakumar R
Colloids Surf B Biointerfaces; 2015 Mar; 127():105-13. PubMed ID: 25660093
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
[TBL] [Abstract][Full Text] [Related]
15. Electrospun Patch Functionalized with Nanoparticles Allows for Spatiotemporal Release of VEGF and PDGF-BB Promoting In Vivo Neovascularization.
Tsao CJ; Pandolfi L; Wang X; Minardi S; Lupo C; Evangelopoulos M; Hendrickson T; Shi A; Storci G; Taraballi F; Tasciotti E
ACS Appl Mater Interfaces; 2018 Dec; 10(51):44344-44353. PubMed ID: 30511828
[TBL] [Abstract][Full Text] [Related]
16. Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair.
Sakiyama-Elbert SE; Das R; Gelberman RH; Harwood F; Amiel D; Thomopoulos S
J Hand Surg Am; 2008 Nov; 33(9):1548-57. PubMed ID: 18984337
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
18. A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo.
Liu G; Wu R; Yang B; Shi Y; Deng C; Atala A; Mou S; Criswell T; Zhang Y
Acta Biomater; 2020 Apr; 107():50-64. PubMed ID: 32044457
[TBL] [Abstract][Full Text] [Related]
19. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
Raja MA; Katas H; Jing Wen T
PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
[TBL] [Abstract][Full Text] [Related]
20. Stable emulsions prepared by self-assembly of hyaluronic acid and chitosan for papain loading.
Zhao D; Wei W; Zhu Y; Sun J; Hu Q; Liu X
Macromol Biosci; 2015 Apr; 15(4):558-67. PubMed ID: 25594587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
